Literature DB >> 723783

Vaccine against hepatitis B--18 months prevention in a high risk setting.

P Maupas, A Goudeau, P Coursaget, J Drucker, P Bagros, S Baudin, N Geslin.   

Abstract

The development of a vaccine against hepatitis B prepared with purified and inactivated HBs Ag is described. This vaccine has been applied in patients and staff members of haemodialysis centres. Safety and efficiency of the vaccine are very satisfactory. The response of patients to immunisation was significantly lower compared to the response of the staff members. None of the volunteers who had a primary response to immunisation developed signs of clinical or biological hepatitis.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 723783     DOI： 10.1007/bf02121140

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  19 in total

1.  The binding of detergents to lipophilic and hydrophilic proteins.

Authors:  A Helenius; K Simons
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

2.  Prevention of virus B hepatitis (SH hepatitis).

Authors:  J P Soulier; C Blatix; A M Courouce; D Benamon; P Amouch; J Drouet
Journal:  Am J Dis Child       Date:  1972-04

3.  Hepatitis B antigens: separation of two populations differing in particle size distribution.

Authors:  A R Neurath; L Cosio; A M Prince; A Lippin; H Ikram
Journal:  Proc Soc Exp Biol Med       Date:  1973-06

4.  [Concentration of virus by polyethylene-glycol].

Authors:  G Calothy; M Digeon; M Raynaud
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1967-11-27

5.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

6.  Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

7.  Isolation of hepatitis B surface antigen (HBsAg) by affinity chromatography on antibody-coated immunoadsorbents.

Authors:  B Houwen; A Goudeau; J Dankert
Journal:  J Immunol Methods       Date:  1975       Impact factor: 2.303

8.  Immunisation against hepatitis B in man.

Authors:  P Maupas; A Goudeau; P Coursaget; J Drucker; P Bagros
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

9.  Hepatitis B vaccine: efficacy in high-risk settings, a two-year study.

Authors:  P Maupas; A Goudeau; P Coursaget; J Drucker; P Bagros
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

10.  Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report.

Authors:  S Iwarson; H Kjellman; J Ahlmén; C Ljunggren; E Eriksson; D Selander; S Hermodsson
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378
View more
  2 in total

1.  [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].

Authors:  B Stamm; W Gerlich; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-05-15       Impact factor: 3.402

2.  Hepatitis among hospital employees.

Authors:  D L Palmer; M Barash; R King; F Neil
Journal:  West J Med       Date:  1983-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.